bioecon Member area
Suppliers · Services / consulting · Food biotech

Esco Aster

Esco Aster is a vertically integrated bioinnovation venture accelerator delivering end-to-end “idea-to-exit” contract solutions—from consultancy and research to CMC development, manufacturing, testing, clinical development, strategic fundraising and enterprise support. We provide phase-appropriate capabilities that scale with our collaborators, sponsors, and partners—from early development …

active SingaporeAsia Founded 2015 checked 2026-10-05

Profile

Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and collaborators translate and scale cell- and cell-derivative technologies “idea-to-exit,” operating two dedicated certified sites for clinical/veterinary/dermocosmetics and for cell-based nutrition/nutricosmetics. Core products/technology center on Tide Motion adherent packed-bed bioreactors (closed automated cell harvesting; linear scale concept noted from 0.1 L to 5,000 L packed-bed volume, and scales up to 55,000 L), plus continuous fermentation and food/cellular agriculture via AsterMavors (complementary proteins). Founded/established in 2015 within Esco Lifesciences Group; spun out as a wholly owned subsidiary in 2018; completed spin-off in 2022 and operates as an affiliate of Esco Lifesciences Group. Headquarters include Singapore (Ayer Rajah Crescent; e.g., #02-01 Blk 67). Scale: the Esco Lifesciences Group is listed as having 1,700 employees and 42 locations (25 countries), but no Esco Aster-specific revenue/capacity/employees figures were provided. Ownership/listing/investors/funding: no stock listing or named investors were given; “Strategic Capital” is described as a fundraising-as-a-service for accredited investors and capital providers, not a disclosed funding round. Key partners/customers named: Shine-On Biomedical (exosome clinical cGMP manufacturing contract); also MOUs with Creative Life Science (Taiwan) and references to collaborations with Institute of Molecular Cell Biology and Bioprocessing Institute. Latest 2025–2026 developments: December 2025 MOU with Creative Life Science; July 2026 CelShaker™ automated cell harvesting system launch; September 2026 interview/feature reporting expansion from CRDMO to broader bioinnovation venture accelerator; and December 12, 2025 exosome manufacturing contract news was dated earlier in the feed. Still active: yes, with news published as late as 2026-09-16.

Sources#

Industry
Alternative proteins, Bioprocess equipment, Fishery & aquaculture, Food ingredients, Paints & coatings, Seeds & genetics, Veterinary
Topics
Vitamins, carotenoids & nutraceutical actives, Animal & aquaculture vaccines
Role
Services / consulting — “…r business model centers on consultancy to transform ideas and IP into spin-offs, acting as a launchpad to bui…”

Bio-solutions it supplies 1

D1Fermentation (stainless and single-use bioreactors, solid-state reactors) and downstream equipment (centrifuges, filtration, spray and fluid-bed drying, formulation) for local production of enzymes, microbial products and fermentation ingredients instead of chemical-synthesis plants and imports

What they offer

Products: Cell-based cultivated meat; Cell-based chicken paste; Engineered cancer exosomes; Induced Retinal Pigment Epithelium (RPE); BioNOC™ II; CelCradle™; TideXcell™; Tide Motion Platform; GlucCell™; Esco VacciXcell GlucCell™ Glucose Test Strips

Certifications: ISO 9001:2015; ISO 22000:2018; FSSC 22000; My Green Lab Certification

Applications
Human Vaccines · Mesenchymal Stem Cells · Animal Health · Vaccine Production · Biologics and Cell Therapy Production · Cell Therapy · Gene-edited Cell Therapy · Human Vaccines/Oncolytic Viruses · Therapeutic mAbs/Recombinant Protein · Gene Therapy · Food Ingredient/Product Protein · Biomass for Cell-Based Meat Food Formulation
Certifications (website)
ISO 9001:2015 · ISO 22000:2018 · FSSC 22000 · My Green Lab Certification
Customers & partners
Nuvonis Technologies GmbH · patients
Production sites
#02-01, Blk 67 Ayer Rajah Crescent, Singapore 139950 — Cells/Viruses/EVs · #02-04 Blk 67 Ayer Rajah Crescent, Singapore 139950 — Clinical Trial Material Operations · #03-20 Blk 71 Ayer Rajah Crescent, Singapore 139951 — Cellular Agriculture and Complementary Proteins (Food) · 36, 20th Road, Taichung Industrial Park, Taichung, 40850 Taiwan — Bioengineering · Semba LS Bldg.4F,3-6-62, Sembahigashi, Minoh-city, Osaka 〒562-0035, Japan — Japan Head Office · LiSH Lab, NORTH 6F, 2-21-1 Takanawa, Minato-ku, Tokyo 〒108-0074, Japan — Takanawa Gateway Lab · Singapore — Vero cell cultivation and vaccine production · Austria — GMP Vero cell line · #02-04 Blk 67 Ayer Rajah Crescent, Singapore 139950 — Esco AsterTide PD-Phase 2 CTM (Cells/Viruses/EVs) · #03-20 Blk 71 Ayer Rajah Crescent, Singapore 139951 — Esco AsterMavors Cellular Agriculture and Complementary Proteins (Food) · #02-01, Blk 67 Ayer Rajah Crescent, Singapore 139950 — Esco Aster Pte. Ltd. · Singapore — Proprietary cell lines, media, other ancillary consumables, and labour
Products (website)
Cell-based cultivated meat — First company to receive a food processing license from the Singapore Food Authority (SFA) to manufacture cell-based cultivated meat for human consumption. · Cell-based chicken paste — Commenced manufacturing under ISO 22000:2018 certification. · Engineered cancer exosomes — Targeting HLA-G; developing clinical trial drug product with contract testing. · Induced Retinal Pigment Epithelium (RPE) — From pluripotent stem cells for Dry AMD (Age-related Macular Degeneration). · BioNOC™ II — Macrocarriers for Vero cell cultivation. · CelCradle™ — Bioreactor technology for Vero cell cultivation. · TideXcell™ — Automated cell harvesting system for high-density cell culture. · Tide Motion Platform — Platform for localized vaccine production using Vero cells. · GlucCell™ — Device for measuring glucose levels in cell growth assays. · Esco VacciXcell GlucCell™ Glucose Test Strips — Test strips for glucose measurement. · TideMotion® Bioreactors — Platform for scalable culture of adherent cells. · CelCradle™ Bioreactor — Used in the production of viral vectors.
R&D facilities
Austria

Read from the company's own website: about · products · production · quality · rnd · contact · sustainability · topic

News & status 6

Network: owners, partners, peers

Ownership & investors 1

parentEsco Lifesciences Group

Similar companies

ScaleUp Bio · Cell AgriTech · Laurus Bio · ULTIMEAT · Shiok Meats · IntegriCulture inc.（インテグリカルチャー株式会社） · Provis Biolabs · CellX

Identity & contacts

Contacts, people and legal identity are available to members.

Sign in as a member